Growth Metrics

Novavax (NVAX) Non-Current Assets (2016 - 2025)

Historic Non-Current Assets for Novavax (NVAX) over the last 17 years, with Q3 2025 value amounting to $205.3 million.

  • Novavax's Non-Current Assets fell 6627.83% to $205.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.5 billion, marking a year-over-year decrease of 4094.57%. This contributed to the annual value of $431.5 million for FY2024, which is 3398.49% down from last year.
  • Latest data reveals that Novavax reported Non-Current Assets of $205.3 million as of Q3 2025, which was down 6627.83% from $417.0 million recorded in Q2 2025.
  • Novavax's 5-year Non-Current Assets high stood at $653.6 million for Q4 2023, and its period low was $205.3 million during Q3 2025.
  • Over the past 5 years, Novavax's median Non-Current Assets value was $487.5 million (recorded in 2022), while the average stood at $493.1 million.
  • In the last 5 years, Novavax's Non-Current Assets soared by 39643.31% in 2021 and then plummeted by 6627.83% in 2025.
  • Over the past 5 years, Novavax's Non-Current Assets (Quarter) stood at $421.6 million in 2021, then surged by 31.7% to $555.3 million in 2022, then increased by 17.71% to $653.6 million in 2023, then crashed by 33.98% to $431.5 million in 2024, then plummeted by 52.42% to $205.3 million in 2025.
  • Its Non-Current Assets was $205.3 million in Q3 2025, compared to $417.0 million in Q2 2025 and $425.0 million in Q1 2025.